Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/ZYMEWORKS-INC-34658200/news/Zymeworks-Inc-Reports-Preliminary-Phase-1-Trial-Results-for-Zanidatamab-Zovodotin-At-European-Socie-41759754/?utm_source=whatsapp&utm_medium=social&utm_campaign=share